Human Adipokine 5-Plex Discovery Assay® Array (serum/plasma) (HDADK5)

Description

This assay uses the Luminex® 200™ platform.

Consider this assay for detailed analysis of adipokines in serum and plasma samples. The Human Adipokine 5-Plex Discovery Assay® Array helps understand adipokine levels related to metabolic and cardiovascular health.

This panel provides insights into adipokine profiles relevant to obesity, diabetes, and cardiovascular diseases. Adiponectin and Resistin are crucial for understanding metabolic regulation and insulin sensitivity, while Adipsin plays a role in inflammation and metabolic disorders. Lipocalin-2/NGAL is associated with inflammation and cardiovascular risk, and PAI-1 (total) is important for assessing fibrinolysis and thrombotic risk.

Optimized for serum and plasma samples, this assay allows for detailed investigation of adipokine levels and their implications in metabolic syndromes and related conditions.

For a more comprehensive immune profile, consider running our most popular human array, the Human Cytokine/Chemokine Panel A 48-Plex Discovery Assay® Array (HD48A) in addition to this assay. The HD48A is our most popular human array, providing an extensive cytokine and chemokine profile by measuring 48 biomarkers simultaneously from a small sample volume. This powerful assay includes essential biomarkers such as IL-6, TNFα, VEGF-A, and IL-10, providing a broad view of immune responses and inflammatory pathways. Combining these assays will give you a more detailed and holistic understanding of the immune landscape in your research models.

Discover the power of precision with our assay, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency. Streamline your research and unlock a new level of detail with our advanced multiplex assay solution.

Click here for information on shipping biological samples for Discovery Assays  

Published Research Featuring Our HDADK5:

1. Nature! Klein, J., Wood, J., Jaycox, J. R., Dhodapkar, R. M., Lu, P., Gehlhausen, J. R., Tabachnikova, A., Greene, K., Tabacof, L., Malik, A. A., Monteiro, V. S., Silva, J., Kamath, K., Zhang, M., Dhal, A., Ott, I. M., Valle, G., Peña-Hernández, M., Mao, T., … Iwasaki, A. (2023). Distinguishing features of long COVID identified through immune profiling. Nature, 623(139-148).
2. Huang, X., Maguire, O. A., Walker, J. M., Jiang, C. S., Carroll, T. S., Luo, J. D., Tonorezos, E., Novetsky Friedman, D., & Cohen, P. (2021). Therapeutic radiation exposure of the abdomen during childhood induces chronic adipose tissue dysfunction. JCI Insight, 6(21), e153586. 
3. Dugger, D. T., Fung, M., Zlock, L., Kleinhenz, M. E., Langelier, C., & Greenland, J. R. (2020). Cystic fibrosis lung transplant recipients have suppressed airway interferon responses during Pseudomonas infection. Cell Reports Medicine, 1(4), 100055.
4. Grady, C. B., Bhattacharjee, B., Silva, J., Jaycox, J., Lee, L. W., Silva Monteiro, V., Sawano, M., Massey, D., Caraballo, C., Gehlhausen, J. R., Tabachnikova, A., Mao, T., Lucas, C., Peña-Hernandez, M. A., Xu, L., Tzeng, T. J., Takahashi, T., Herrin, J., Berrent Güthe, D., … Krumholz, H. M. (2024). Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVID. medRxiv.